Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Clinical trial NCT04880395 · COMPLETED

Trial details

NCT number: NCT04880395
Sponsor: Fundación Huésped
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2021-05-17
Primary completion: 2024-05-07
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.